Bayer Hyrnuo secures USFDA accelerated approval for previously treated advanced HER2 mutant non small cell lung cancer Ruchika Sharma21 Nov 2025 1:30 PM ISTBerlin: Bayer has received accelerated approval from the U.S. Food and Drug Administration (FDA) for HYRNUO (sevabertinib),for the treatment of...
Bayer Lynkuet approved in EU for hot flashes Ruchika Sharma20 Nov 2025 10:30 AM ISTBerlin: Bayer has announced that the European Commission has granted marketing authorization in the European Union (EU) for elinzanetant, under...
Bayer Lynkuet gets USFDA nod for treatment of moderate to severe vasomotor symptoms due to menopause Ruchika Sharma25 Oct 2025 11:30 AM ISTBerlin: Bayer has received approval for elinzanetant from the U.S. Food and Drug Administration (FDA) as the dual neurokinin (NK)...
Shilpa Medicare gets initial authorization from EMA for Rivaroxaban Orodispersible Films Ruchika Sharma23 Sept 2025 12:30 PM ISTBengaluru: Shilpa Medicare Limited, headquartered at Raichur, Karnataka, India, has received the initial authorization from European...
Bayer new drug application for gadoquatrane accepted for review in China Ruchika Sharma21 Sept 2025 2:00 PM ISTBerlin: Bayer today announced that the Center of Drug Evaluation of China's National Medical Products Administration has accepted the new drug...
Bayer Elinzanetant recommended for nod in EU for moderate to severe vasomotor symptoms Ruchika Sharma20 Sept 2025 2:04 PM ISTBerlin: Bayer has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...
Tata Elxsi inaugrates Bayer Development Centre in Radiology at Pune Ruchika Sharma11 Sept 2025 2:12 PM ISTPune: Tata Elxsi has announced the inauguration of the 'Bayer Development Centre in Radiology' at Tata Elxsi, Pune, India.The centre is designed...
Bayer Gadoquatrane new drug application accepted for review by USFDA Ruchika Sharma27 Aug 2025 2:30 PM ISTBerlin: Bayer has announced that a New Drug Application (NDA) for its investigational contrast agent gadoquatrane has been accepted for review by...
Bayer, Kumquat Biosciences ink pact to develop, commercialize KRAS G12D inhibitor Ruchika Sharma15 Aug 2025 10:00 AM ISTBerlin: Bayer and Kumquat Biosciences Inc., a clinical-stage biotech company, have announced that they have entered into an exclusive global...
Bayer Sevabertinib accepted for review in China for advanced non-small cell lung cancer Ruchika Sharma29 July 2025 11:30 AM ISTBerlin: Bayer has announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has accepted for...
Menopause relief drug: USFDA extends review period for Bayer Elinzanetant Ruchika Sharma27 July 2025 3:45 PM ISTBerlin: Bayer has announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for...
Bayer Nubeqa gets EU nod in third indication for advanced prostate cancer Ruchika Sharma22 July 2025 10:30 AM ISTBerlin: Bayer has received marketing authorization from the European Commission in the European Union (EU) for Nubeqa (darolutamide), an oral...
